5/12/2025CureGene Unveils Potent Liver-Targeted THR-β Prodrug CG-0416 with Pro...

5/12/2025AusperBio Reports Promising Phase IIb Results for AHB-137 in Chronic H...

5/12/2025Lepu's Miracogen Launches Phase 3 Trial of Novel EGFR-Targeting ADC Co...

5/7/2025Roche's Columvi Wins Expanded Approval in China for 2L+ DLBCL

5/7/2025Everest Medicines Announces NMPA Full Approval of NEFECON

5/7/2025Early Clinical Data from China Show Promise for In Vivo CAR-T Therapie...

5/6/2025Immunochina’s IM96 CAR-T Cell Therapy Wins FDA IND Clearance

5/6/2025China Approves Six Novel Drugs in April 2025, Marking Significant Adva...

5/6/2025Kintor Reports Superior Hair Regrowth Results for KX-826 and Minoxidil...

5/6/2025CStone Unveils Promising Preclinical Data for Trispecific Antibody CS2...

4/29/202553 Original Research Drugs Approved in China in Early 2025

4/29/2025BeiGene's Novel Cancer Drug Sonrotoclax Seeks Approval in China

4/29/2025Innovent Announces NMPA Approval of Limertinib

4/29/2025Frontera's Gene Therapy FT-017 Achieves Dual Regulatory Clearance in U...

4/29/2025XellSmart Receives NMPA Approval for Landmark Trial of "On-Demand" iP...

4/29/2025CentyMed's Novel EGFR/CD3 BsAb CMDE005 Receives FDA Green Light for Cl...

4/29/2025Innovent Initiates Global Phase 1 Trial for ADC IBI3020

4/29/2025Akeso's BsAb Shows Promising Survival Benefit in Lung Cancer Trial

4/25/2025China Greenlights Recordati's Long-Acting Pasireotide for Uncontrolled...

4/25/2025Akeso's Ivonescimab Gains Second Approval in China

4/25/2025Akeso's Penpulimab Secures FDA Approval for Nasopharyngeal Carcinoma

4/25/2025NMPA Approves Expanded Use of JNJ's Rybrevant for Advanced EGFR-Mutate...

4/24/2025Akeso's Ivonescimab Outperforms Tislelizumab in Phase III Trial for sq...

4/22/2025AZ's Ultomiris for Generalized Myasthenia Gravis in China

4/22/2025China Approves New Indication of Opdivo for NSCLC

4/22/2025Kelun-Biotech's ADC SKB518 Wins U.S. FDA IND Clearance

4/22/2025Ensem Thera Advances China-Linked Oncology Program with U.S. FDA IND C...

4/22/2025Zai Lab's Repotrectinib sNDA Accepted by China NMPA

4/22/2025Hengrui Initiates Phase I Trial for Novel Obesity siRNA Drug HRS-5817 ...

4/19/2025Akeso's Ebdarokimab Approved in China as First Domestic IL-12/IL-23 An...

Page:12/20 Total number of articles:592: [First][<<] [10] [11] [12] [13] [14] [>>] [End]